Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Merck Launches New MILLIPLEX Human Metabolic Hormone Panel V3

Products are for professional/laboratory use only.  Abacus dx is pleased to announce the launch of the new MILLIPLEX Human Metabolic Hormone Panel V3, a 14-plex customisable panel.

Metabolic syndrome is a cluster of conditions that occur together, including increased blood pressure, elevated insulin levels, excess body fat around the waist, and abnormal cholesterol levels. Key features of metabolic syndrome include insulin resistance, glucose intolerance, hypertension, dyslipidemia, and central obesity—all of which are risk factors for atherosclerosis, coronary heart disease, type 2 diabetes, kidney disease, and even premature death.

Adults with metabolic syndrome show a low-grade inflammation, whose link with obesity may be dysregulated adipocyte production of pro- and anti-inflammatory factors. Consequently, research done in this area covers cytokines, acute phase proteins, diabetes and obesity related hormones, as well as other cardiovascular disease biomarkers.

The MILLIPLEX Human Metabolic Hormone Panel V3 is a 14-plex kit to be used to quantify any or all of the following analytes in human serum, plasma, tissue/cell lysates and culture supernatant.

The Merck MILLIPLEX® Human Metabolic Hormone Panel V3 offers you:

  • The ability to choose any combination of analytes from the panel of 14 analytes to design a custom kit that better meets your needs.
  • A convenient “all-in-one” box format that gives you the assurance that you will have all the necessary reagents you need to run your assay.

 

MILLIPLEX® Human Metabolic Hormone Panel V3 Analytes:


Ordering Information:

  • MPHMH334K, Human Metabolic Hormone Panel V3

Discover other Merck MILLIPLEX products

View Latest Analyte Update >

Request a Quote

Contact Us >



Request a Quote

Request Quote

Recent Posts

Developing Diagnostic Kits for Ovarian Cancer

In Australia, ovarian cancer is the deadliest reproductive cancer. The average five‑year survival rate sits at around 49%, compared with about 92% for breast cancer,…

Read full article

Merck FemtoQuest™

Gain your desired immunoassay sensitivity with the ultrasensitive FemtoQuest™ system Measure down to femtogram/mL levels Improved precision and robust data Perform dual-plex and single analyte…

Read full article

Healing Eyes with Precision: Research Empowered by Merck’s MILLIPLEX® Technology

Imagine using part of your blood to help heal your eyes A study by Liu et al. (2025) explores a new way to treat corneal neovascularization, a condition…

Read full article